Key Takeaway:
- GLP-1 weight loss drugs offer an effective non-surgical option but require medical supervision and long-term commitment.
- Benefits include weight loss, improved fullness, diabetes control, and possible heart protection.
- Exercise, monitoring, and personalized treatment plans remain essential for safe and lasting results.
A Jacksonville bariatric surgeon says GLP-1 agonist medications such as Ozempic and Wegovy offer new weight-loss options, but patients must understand the benefits, risks, and long-term commitments before starting weekly injectable treatments.
Doctor Says GLP-1 Drugs Expand Weight-Loss Options
As demand grows for medical weight-loss solutions, a bariatric surgeon at HCA Florida Memorial Hospital says GLP-1 agonists are changing how doctors treat obesity and related health conditions.
Dr. Husain Abbas said the medications provide an alternative for patients who struggle with traditional weight-loss methods or who may not be ready for surgery.
“When these medications came on the market, I think they have been a lifeline to our patients because it gives us another option,” Abbas said.
GLP-1 agonists, including widely recognized brands such as Ozempic, Wegovy, and Mounjaro, are injectable drugs typically taken once a week. Doctors prescribe them to help patients manage weight by increasing feelings of fullness and slowing digestion.
Abbas said many patients seeking treatment have already tried diet and exercise programs without lasting results.
“A lot of times people are told, ‘If you just exercise more and eat less, then you will lose the weight,’” he said. “But obesity is more complex than that.”
Health experts note that the medications can also improve blood sugar control and may provide cardiovascular benefits, particularly for patients with diabetes or metabolic conditions.
Experts Warn Of Side Effects And Monitoring Needs
Despite growing popularity, Abbas cautioned that GLP-1 weight loss drugs are not risk-free and require ongoing medical supervision.
Common side effects include nausea, vomiting, bloating, and abdominal pain. Physicians also monitor electrolyte levels through regular blood work to prevent complications.
“While you may not actually see the effects of abnormalities in your electrolytes, it is extremely important that somebody looks at those,” Abbas said. “Low potassium, for example, can cause heart issues.”
The U.S. Food and Drug Administration recommends a once-weekly dosing schedule, though physicians continue studying whether lower doses may work for some patients.
Abbas emphasized that patients should obtain prescriptions only from licensed medical providers rather than unregulated sources, warning that improper dosing or lack of monitoring can increase health risks.
Surgery and Medication Often Work Together
Abbas said a common misconception is that weight-loss medication replaces lifestyle changes or surgical treatment.
Exercise, particularly resistance training and weightlifting, remains essential during medical weight loss to prevent muscle loss.
“The biggest challenge is when you lose so much weight, you lose a lot of your lean mass,” Abbas said. “A lot of your muscle mass decreases.”
He added that treatment plans vary widely. Some patients benefit from medication alone, while others may combine injections with bariatric surgery for long-term success.
Doctors evaluate factors such as overall health, weight history, and patient goals before recommending an approach. In some cases, surgery may come first, followed by medication to maintain weight loss.
Abbas said the growing range of treatments allows physicians to tailor care instead of relying on a single solution.
“We are still learning,” he said, noting ongoing research into dosing strategies and long-term outcomes.
Medical professionals stress that GLP-1 agonists work best when paired with nutrition counseling, physical activity, and close follow-up care.
As interest in medical GLP-1 weight loss drugs treatments continues to rise nationwide, experts encourage patients to seek individualized guidance and realistic expectations about results and maintenance.
